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 1 
Systematic review 1 
Is Knee joint distraction a viable treatment option for knee OA? - a literature review and 2 
meta-analysis 3 
 4 
Abstract 5 
Background: Knee joint distraction (KJD) is a new application of an established 6 
technique to regenerate native cartilage using an external fixator. The purpose of this 7 
study is to perform a systematic review and meta-analysis of the literature to determine 8 
whether KJD is beneficial for knee osteoarthritis and how results compare to established 9 
treatments. 10 
Methods: Studies assessing the outcomes of KJD were retrieved, with three studies 11 
(one cohort, two randomized controlled trials), 62 knees, meeting inclusion criteria. The 12 
primary outcome was functional outcome, assessed using a validated outcome score, at 13 
one year. Secondary outcomes included: pain scores, structural assessment of the joint 14 
and adverse events. 15 
 2 
Results: KJD is associated with improvements in WOMAC from baseline to one year 16 
as well as reductions in pain scores and improvements in structural parameters assessed 17 
radiographically and by MRI. KJD is not associated with decreased knee flexion, but is 18 
associated with a high risk of pin site infection. In patients aged 65 years or under at one 19 
year no differences in WOMAC or pain scores was detected between patients managed 20 
with KJD compared to high tibial osteotomy or total knee arthroplasty.  21 
Conclusions: KJD may represent a potential treatments for knee arthritis though further 22 
trials with longer term follow up are required to establish its efficacy compared to 23 
contemporary treatments. 24 
 25 
Keywords: 26 
Knee osteoarthritis; knee joint distraction; total knee arthroplasty; high tibial osteotomy; 27 
outcomes; complications. 28 
 29 
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 3 
Introduction 32 
Knee osteoarthritis (OA) is the most common musculoskeletal disease 33 
HVWLPDWHG WR HIIHFW  RI WKH ZRUOG¶V SRSXODWLRQ [1]. Considered a disease of the 34 
whole joint, knee OA is characterized by loss of cartilage, bone remodeling and 35 
inflammation. Cumulative joint degeneration eventually leads to substantial loss of 36 
function and quality of life, and represents a major cause of global disability [1,2]. The 37 
burden of OA is set to increase with rising obesity levels and an ageing population [1,3]. 38 
Gold standard treatment for OA of significant severity is joint arthroplasty after initial 39 
conservative treatment. Beyond arthroplasty, no other treatment is proven effective in 40 
halting or reversing disease progression. Globally, the prevalence of knee OA peaks at 41 
50 years [1]. However, both patients and surgeons are reluctant to replace joints where 42 
the patient is expected to outlive the lifespan of the prosthesis as there is a greater risk 43 
of revision surgery [4-6].  44 
Consequently, there is an increasing need for alternative treatments for this 45 
younger OA population. Not least because of the increased failure risk [5] but also 46 
because in some cases arthroplasty may result in poor clinical outcomes [7]. Following 47 
 4 
injury and osteoarthritis in the ankle, ankle joint distraction has provided a useful means 48 
of reducing pain, improving function and increasing radiological joint space [8]. 49 
Likewise basilar thumb arthritis has been effectively treated with joint distraction and 50 
debridement in small prospective studies [9]. There are a certain risks of infection at pin 51 
sites and related bone infection often observed in any surgical procedure using external 52 
frame and pins or wires, however, such joint sparing alternatives are useful for patients 53 
who wish to preserve the native joint. 54 
A similar approach has been adopted to treat knee OA with knee joint 55 
distraction (KJD). KJD uses an external fixator to unload the joint by distracting the 56 
tibia and femur [10]. It is reported that this temporary mechanical unloading allows 57 
natural intrinsic repair processes to regenerate cartilaginous tissue evidenced by a 58 
sustained clinical benefit and increase in joint width space [11]. With KJD being a joint 59 
sparing procedure aimed at postponing a first prosthesis, successful clinical adoption 60 
FRXOG VLJQLILFDQWO\ LPSURYH SDWLHQWV¶ TXDOLW\ RI OLIH DQG WKXV UHGXFH WKH ORQJ-term 61 
healthcare costs associated with knee OA. 62 
The aims of this systematic review are to identify and examine the current 63 
 5 
evidence for the use of KJD focusing on clinical and radiological outcomes. This review 64 
will also help to identify gaps in our understanding and so inform future clinical and 65 
scientific studies.66 
 6 
 67 
Material and methods 68 
Inclusion and exclusion criteria 69 
 Eligible studies included those involving patients aged 18 years or older with 70 
knee arthritis that compared surgical KJD against other surgical procedures for knee 71 
arthritis. There were no exclusions based study design or duration of distraction.  72 
 73 
Information Sources and Search Strategy 74 
Electronic databases (MEDLINE (Ovid), EMBASE (Ovid), Web of Science 75 
(ISI Web of Knowledge)) were searched from their inception until 25 February 2018 for 76 
studies meeting inclusion criteria. Searches were tailored to individual databases with 77 
the search strategy for MEDLINE shown in Appendix 1. In addition, reference lists of 78 
reviews and retrieved articles were assessed for further studies as were registers of 79 
controlled clinical trials (metaRegister of controlled trials (mRCT) 80 
(www.controlled-trials.com/mrct), clinicaltrials.gov (www.clinicaltrials.gov) and the 81 
World Health Organization (WHO) International Clinical Trials Registry Platform 82 
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(ICTRP) (http://apps.who.int/trialsearch/)). No restrictions were applied based on the 83 
publication status. Where necessary authors were contacted for additional information. 84 
Studies were assessed independently in duplicate for eligibility and data from 85 
eligible studies extracted independently in duplicate into an electronic database (TT, 86 
TWH). A risk of bias assessment was performed on included studies. 87 
 88 
Outcome measures assessed 89 
 To assess the outcome of KJD improvements from baseline to one year post 90 
intervention were assessed. To compare KJD with other surgical interventions outcomes 91 
at one year post intervention were assessed. 92 
 The primary outcome assessed was functional outcome, assessed using a 93 
validated outcome score, at one year following surgical intervention. Secondary 94 
outcomes included: pain scores, assessed using a validated pain score, structural 95 
assessment of the joint, both radiographic and with MRI and assessment of adverse 96 
events. All secondary outcomes were assessed at one year following surgical 97 
intervention. 98 
 8 
 99 
Statistical analysis 100 
 Heterogeneity of included studies was assessed using the I2 statistic and in the 101 
event of substantial heterogeneity (I2>85%) a meta-analysis was not be performed. As a 102 
degree of variability was expected due to the subjectivity of the outcome measures a 103 
random-effects model was used in all cases. For continuous data the mean difference 104 
(MD) was calculated along with 95% confidence-intervals (95%CI), calculated using 105 
the inverse variance method. For dichotomous data the risk difference along with 106 
95%CI was calculated using the Mantel-Haenszel method. Data analysis was performed 107 
using standard statistical techniques as described in the Cochrane Handbook for 108 
Systematic Reviews of Interventions, using Review Manager-5.3 (The Nordic Cochrane 109 
Centre, The Cochrane Collaboration, 2014).110 
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 111 
Results 112 
 Three studies consisting of one cohort study and two 113 
randomized controlled trials were identified as meeting inclusion criteria [11-13]. 114 
Figure 1. The results of the cohort study were reported across three papers with relevant 115 
data extracted where reported [11,14,15]. Included studies are outlined in Table 1 with 116 
an assessment of risk of bias presented in Figure 2. All studies were considered at high 117 
risk of performance and detection bias as it was not possible to blind surgeons, 118 
participants or outcome assessors as to the treatment received. Attrition and reporting 119 
bias was assessed as low risk with no loss to follow up at one year reported. As all three 120 
studies originate from the same research group it was consider that this presented an 121 
unclear risk of bias. 122 
 Two studies were excluded as they reported the results of arthroscopic 123 
microfracture in combination with KJD and it was the authors opinion that, as 124 
microfracture is already an established treatment for cartilaginous loss, it would not be 125 
possible to delineate any treatment effect seen [16,17]. The first of these studies by Deie 126 
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et al. (2007) reported the outcomes of six knees managed with KJD and microfracture 127 
and found at a mean 3 year follow up significant improvements in Japanese Orthopaedic 128 
Association Score, VAS pain score and radiographic joint space width [16]. The second, 129 
by Aly et al. (2011), reported the outcomes of 61 knees, 19 managed with KJD, joint 130 
debridement and microfracture and 42 managed with joint debridement and 131 
microfracture and found that at a mean follow up of 3 to 5 years the group managed 132 
with KJD, joint debridement and microfracture had significantly improved pain, 133 
walking capacity, stair climbing and radiographic joint space width compared to 134 
baseline whereas those treated with joint debridement and microfracture without KJD 135 
did not [17].  136 
 137 
Outcomes of KJD improvement from baseline to one year post intervention 138 
Primary Outcome 139 
 The Western Ontario and McMaster Universities Osteoarthritis Index 140 
(WOMAC) scores at baseline and one year post KJD were reported in all 3 studies, 62 141 
patients, with a significant improvement in WOMAC scores, mean difference 28.7 142 
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points (p<0.001; 95%CI 22.6 to 34.8), between baseline and one year post surgery 143 
observed. Figure 3. Improvements were seen across all subdomains of WOMAC: pain 144 
(p=<0.001; MD 29.3 points 95%CI 21.9 to 36.5), stiffness (p=<0.001; MD 19.5 points 145 
95%CI 8.4 to 30.6) and function (p=<0.001; MD 29.5 points 95%CI 23.6 to 35.4). 146 
 KOOS, ICOAP, EQ-5D and SF-36 were reported in 2 studies, 42 patients. 147 
Significant improvements between baseline and one year scores were observed for 148 
KOOS (p<0.001, MD 23.2 points 95%CI 15.4 to 31.1), ICOAP (p<0.001, MD 26.7 149 
points 95%CI 17.0 to 36.4) and EQ-5D (p<0.001, MD 0.15 points 95%CI 0.06 to 0.23) 150 
and all subdomains. Significant improvements between baseline and one year SF-36 151 
physical component score (p=0.009, MD 7.8 points 95%CI 1.9 to 13.7), but not mental 152 
component score (p=0.41, MD -1.5 points 95%CI -5.0 to 2.0) were observed. 153 
 154 
Secondary outcomes 155 
 Pain score, assessed using a pain visual analogue score (VAS) 0 to 100 where 156 
0 was equivalent to no pain, were reported in all 3 studies, 62 patients. Patients 157 
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managed with KJD reported significant improvements in pain VAS of 33.3 points 158 
(p=<0.001; 95%CI 19.7 to 46.9) from baseline to one year post surgery. Figure 4. 159 
Structural assessment of the joint was performed radiographically in all 3 studies, 59 160 
patients, and by MRI in one study, 20 patients. Between baseline and one year 161 
following KJD the radiographic minimum joint space width increased by 0.8mm 162 
(p<0.001; 95%CI 0.5 to 1.0; Figure 5) and mean joint space width increased by 0.8mm 163 
(p=0.003; 95%CI 0.3 to 1.3). On MRI the mean cartilage thickness over the total 164 
subchondral bone area increased from 1.4mm (SD 0.3) to 1.6mm (SD 0.3; p=0.03) on 165 
the tibia and from 1.0mm (SD 0.4) to 1.4mm (SD 0.3; p<0.001) on the femur. The 166 
percentage of denuded subchondral bone decreased from 16.7% (SD 17.2) to 4.8% (SD 167 
8.3; p=0.006) on the tibia and from 27.3% (SD 25.6) to 4.2% (SD 10.2; p<0.001) on the 168 
femur. 169 
 170 
Adverse events 171 
 Knee flexion was reported in 2 studies, 42 patients. No change in knee flexion 172 
between baseline and one year following KJD was observed (p=0.18; MD 2.4° 95%CI 173 
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-1.1 to 5.9) from baseline to one year post surgery. Across all three studies, 62 patients, 174 
one patient was reported as requiring manipulation under anesthetic at 17 days 175 
following frame removal for stiffness. 176 
 Across all three studies, 62 patients, 42 patients developed single or multiple 177 
pin site infection requiring antibiotics. Overall, the risk of developing pin site infection 178 
was 69% (95%CI 51 to 87). Figure 6. The risk of developing pin site infection requiring 179 
oral antibiotics was 57% (95%CI 33 to 82). The risk of developing pin site infection 180 
requiring intravenous antibiotics was 10% (95%CI 1 to 18%). Overall two patients 181 
required surgical irrigation and debridement with one developing osteomyelitis three 182 
weeks following frame removal.   183 
 Additional adverse events reported with the use of KJD included pulmonary 184 
emboli (2 of 20 patients (10%) in one study), post-operative foot drop managed with 185 
ankle foot orthosis (1 patient), failure of the KJD distraction device (1 patient) and 186 
breaking of a bone pin during application (1 patient). 187 
 188 
Outcomes of KJD compared to other treatments 189 
 14 
Primary Outcome 190 
 Two randomized controlled trials assessed the outcomes of KJD against other 191 
treatments for arthritis, one against high tibial osteotomy, one against total knee 192 
arthroplasty. Both studies were conducted in patients aged 65 years and under. At one 193 
year no difference in total WOMAC score, or across subdomains, was seen between 194 
knees managed with KJD and those managed with HTO (p=0.25; MD -5.0 points, 195 
95%CI -13.5 to 3.5) or TKA (p=0.53; MD -3.0 points, 95%CI -12.5 to 6.5). Figure 7. At 196 
one year no difference was seen in KOOS, ICOAP, EQ-5D or SF-36 between treatment 197 
groups. 198 
 Pain score, assessed using a pain VAS 0 to 100 were reported in both studies. 199 
At one year no difference in pain VAS was seen between knees managed with KJD and 200 
those managed with HTO (p=0.17; MD 9.0 points, 95%CI -3.8 to 21.8) or TKA 201 
(p=0.13; MD 10.0 points, 95%CI -3.0 to 23.0). Figure 8. 202 
 203 
Adverse events 204 
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 At one year no difference in knee flexion was seen between knees managed 205 
with KJD and those managed with HTO (p=0.05; MD 4.0 degrees, 95%CI -0.1 to 8.1) 206 
or TKA (p=0.07; MD 5.0 degrees, 95%CI -0.3 to 10.3). No difference in the rate of 207 
manipulation under anesthetic (MUA) was seen between KJD and HTO (p=0.40; RD 208 
0.05 95%CI -0.1 to 0.2). A higher rate of MUA was seen with TKA compared to KJD 209 
(p=0.04; RD 0.14 95%CI 0 to 0.3). 210 
 The risk of developing infection requiring antibiotics was significantly higher 211 
following KJD compared to both HTO (p<0.01; RD 0.5 95%CI 0.3 to 0.8) and TKA 212 
(p<0.01; RD 0.6 95%CI 0.4 to 0.8). This is likely to be secondary to associated risks of 213 
using pins which provide a communication between the external environment and lower 214 
limb bones into which they are placed. 215 
 216 
217 
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Discussion 218 
The main findings of this systematic review are that KJD is associated in 219 
significant improvements in functional scores, pain scores and radiographic measures of 220 
cartilage thickness at one year post-operatively and in patients aged 65 years or younger 221 
has comparable functional outcomes to HTO and TKA. The main limitation of KJD is 222 
the occurrence of pin-tract infection was reported in 69% (95%CI 51 to 87) of patients 223 
and was significantly higher than that seen in HTO or TKA. At one year no difference 224 
in knee flexion, compared to baseline flexion and flexion one year following HTO and 225 
TKA, was seen. Whilst MUA following KJD has been reported (one case across three 226 
studies, 62 patients) the rate of MUA was found to be significantly lower than the rate 227 
observed following TKA. 228 
Compared to older patients, in young patients managed with arthroplasty, the 229 
risk of implant failure, and subsequent revision burden is high and any intervention that 230 
can postpone or reduce the need for the index procedure in this group, and other groups 231 
at risk of poor outcomes, is worth considering. This review has found that KJD appears 232 
to be a potential alternative treatment option in managing knee OA, and in patients aged 233 
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65 years or younger the results appear to be as good as HTO and TKA at one year. 234 
Whilst these results are promising, the high rate of pin site infection following KJD is a 235 
concern because both HTO and TKA can give lower rate of post-operative infection. 236 
Despite in the majority of these cases resolution of infection was achieved with oral 237 
antibiotics. In very few instances, osteomyelitis has been reported, and surgeons may 238 
well have concerns about performing arthroplasty in these cases should KJD fail. 239 
However, Wiegant K, et al. [18] described the safety to perform TKA following KJD 240 
and concluded that it appears safe to treat patients several years following KJD with a 241 
TKA. 242 
 The mechanism by which KJD works is unclear. In the clinical studies of KJD 243 
increased radiographic JSW and coverage of denuded bone assessed by MRI were 244 
reported. Biomarker analysis has reported that following KJD a decrease in the collagen 245 
type II breakdown marker (CTXII) is observed coupled with an increase in the collagen 246 
type II synthesis marker (PIIANP) [14,15]. Whilst these findings would suggest that 247 
KJD changes the intra-articular environment to one that favors cartilage repair. It is 248 
likely that the conflicting results obtained in animal experiments are due to a variety of 249 
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reasons such as differences in experimental set up, type of surrogate endpoints used to 250 
assess cartilage repair and limited follow up. Some studies have shown promising 251 
results with evidence of bone and cartilage repair whilst others have failed to 252 
demonstrate any advantage with KJD, with some even reporting adverse effect on the 253 
cartilage integrity. It is clear from these conflicting observations that more work is 254 
needed to establish indeed when and how joint distraction works and in which scenarios 255 
[19-26]. 256 
Alongside the mechanism of action of KJD there are several other areas of 257 
uncertainty around this treatment. In the present studies static distraction was applied 258 
using two 45 kg springs to permit some degree of joint loading. Whether this represent 259 
the optimum distraction force, and whether a hinged distractor, which has been 260 
demonstrated to be superior for ankle OA, still needs to be assessed [27,28]. 261 
Additionally, the patient population most likely to benefit from distraction and optimum 262 
duration of distraction remains to be defined. Early reports suggest that men with more 263 
severe arthritis are most likely to respond to treatment, and six weeks distraction 264 
provides equivalent clinical outcomes to eight weeks distraction however these findings 265 
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are based on limited data, and appropriately powered trials comparing the outcomes of 266 
KJD to other treatments for knee OA are required [29,30]. Finally, further information 267 
on the long term efficacy of KJD is required. Current data suggests that, at five years 268 
the functional outcomes and structural assessments of joint remain improved compared 269 
to baseline, about 70% of the patients treated still have their own knee instead of the 270 
initially planned joint prosthesis [11]. At 9 years post distraction, still 50% of the 271 
patients continue to manage with their own knee and thereby the need for an artificial 272 
joint is avoided. Remarkably mostly women seem to drop out and opt for further 273 
intervention although there is no clear explanation for this gender difference [31]. 274 
 The strengths of this systematic review are that is a comprehensive 275 
assessment of the efficacy of KJD for the treatment of knee arthritis. The weakness of 276 
this review is that it is limited by the data available, with only three studies available for 277 
inclusion, with all originating from the same research group. 278 
 This study has highlighted that KJD may be a valid alternative to HTO and 279 
TKA in the treatment of knee arthritis in the young, resulting in improvements in 280 
functional and pain as well as evidence of structural improvements within the joint 281 
 20 
lasting beyond one year. However, further work is required to optimize the technique of 282 
KJD, define the optimum population for its use as well as develop methods to reduce 283 
the risk of pin site infection, the major complication associated with this technique. 284 
Ultimately KJD needs to be assessed pragmatically through appropriately powered 285 
multi-center studies designed to assess its long term effectiveness and comparative 286 
efficacy against other established treatments for knee OA.287 
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List of abbreviations 288 
EF: External Fixator 289 
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HTO: High Tibial Osteotomy 291 
JOA: Japanese Orthopaedic Association 292 
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Appendix 1: MEDLINE (Ovid) Search Strategy 317 
1. Knee joint/ 318 
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3. 1. AND 2. 320 
321 
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